CT Centre, AIIMS, Ansari Nagar, New Delhi, 110023, India.
CT Centre, AIIMS, Ansari Nagar, New Delhi, 110023, India.
Indian Heart J. 2024 May-Jun;76(3):154-158. doi: 10.1016/j.ihj.2024.06.003. Epub 2024 Jun 12.
Defining lipid goals solely on low-density lipoprotein-cholesterol (LDL-C) levels in Indian population may cause misclassification due to high prevalence of hypertriglyceridemia and small dense LDL-C particles. International guidelines now recommend Apoliporotein-B (Apo-B) and non-high-density lipoprotein-cholesterol (non-HDL-C) levels as alternative targets. In this study, we used a cross-sectional representative population database to determine Apo-B and non-HDL-C cut-offs corresponding to identified LDL-C targets and compared them to international guidelines.
A community-based survey carried out in urban Delhi and adjacent rural Ballabhgarh provided lipid values for 3047 individuals. The Spearman correlation coefficient was used to evaluate the degree of relationship between Apo-B and LDL-C and non-HDL-C. Cut-off values for Apo-B and non-HDL-C were established using receiver operator curve analysis correlating with guideline-recommended LDL-C targets.
Spearman's rank correlations between Apo-B and LDL-C (0.82) and non-HDL-C and LDL-C (0.93) were significant (p < 0.05). Proposed corresponding cut-off values for LDL-C of 55, 70,100,130 and 160 mg/dl for Apo-B and non-HDL-C in our population were 75.3, 75.5, 91.3, 107.6, 119.4 mg/dL and 92.5,96.5, 123.5, 154.5, 179.5 mg/dL respectively. However, in those with triglycerides >150 mg/dl the corresponding Apo-B and non-HDL-C values were 85.1, 92.7, 103.5, 117.5 and 135 mg/dL and 124.5, 126.5, 147.5, 167.5 and 190.5 mg/L respectively.
Based on this study we provide Apo-B and non-HDL cut-offs corresponding to target LDL-C values in Indian patients with and without high triglycerides. It is noted that in individuals with triglycerides ≥ 150 mg/dl, the Apo-B levels are much higher than the values recommended by guidelines.
在印度人群中,仅基于低密度脂蛋白胆固醇(LDL-C)水平来定义血脂目标可能会导致分类错误,因为高甘油三酯血症和小而密的 LDL-C 颗粒的患病率很高。国际指南现在建议使用载脂蛋白 B(Apo-B)和非高密度脂蛋白胆固醇(non-HDL-C)水平作为替代目标。在这项研究中,我们使用了一项基于人群的代表性横断面数据库来确定与确定的 LDL-C 目标相对应的 Apo-B 和非-HDL-C 截止值,并将其与国际指南进行了比较。
在德里市及其周边农村巴拉班加尔进行的一项社区调查为 3047 个人提供了血脂值。使用 Spearman 相关系数评估 Apo-B 与 LDL-C 和非-HDL-C 之间的关系程度。使用接收者操作曲线分析(Receiver Operator Curve Analysis)根据指南推荐的 LDL-C 目标建立 Apo-B 和非-HDL-C 的截止值。
Apo-B 与 LDL-C(0.82)和非-HDL-C 与 LDL-C(0.93)之间的 Spearman 等级相关系数具有统计学意义(p<0.05)。在我们的人群中,对于 LDL-C 为 55、70、100、130 和 160mg/dl,对于 Apo-B 和非-HDL-C 的相应截止值分别为 75.3、75.5、91.3、107.6、119.4mg/dL 和 92.5、96.5、123.5、154.5、179.5mg/dL。然而,在甘油三酯>150mg/dl 的人群中,相应的 Apo-B 和非-HDL-C 值分别为 85.1、92.7、103.5、117.5 和 135mg/dL 和 124.5、126.5、147.5、167.5 和 190.5mg/L。
基于这项研究,我们提供了印度患者伴有和不伴有高甘油三酯血症时,与目标 LDL-C 值相对应的 Apo-B 和非-HDL 截止值。需要注意的是,在甘油三酯≥150mg/dl 的个体中,Apo-B 水平远高于指南推荐的值。